These tumor-promoting effects can be antagonized by HDAC inhibitors, which block histone deacetylation and thereby inhibit cell proliferation and migration [15,16] and induce cell-cycle arrest [17] and apoptosis [18] of cancer cells. This evidence concerns the gene HDAC9 and cancer.